ABCDE: A Phase II Randomized Study of Adjuvant Bevacizumab, Metronomic Chemotherapy (CM), Diet and Exercise After Preoperative Chemotherapy for Breast Cancer

Trial Profile

ABCDE: A Phase II Randomized Study of Adjuvant Bevacizumab, Metronomic Chemotherapy (CM), Diet and Exercise After Preoperative Chemotherapy for Breast Cancer

Discontinued
Phase of Trial: Phase II

Latest Information Update: 23 Oct 2015

At a glance

  • Drugs Bevacizumab (Primary) ; Cyclophosphamide; Methotrexate
  • Indications Breast cancer
  • Focus Therapeutic Use
  • Acronyms ABCDE
  • Most Recent Events

    • 20 Oct 2015 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov.
    • 29 May 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
    • 15 Jun 2012 Trial phase changed from III to II as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top